SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2E4499203129ABA244B73B4B78A7E62DA89B8969F2DB5FF325580FD416C1789D1DB13C84E0F6B8E5B8271E7DA1A5C45A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2E4499203129ABA244B73B4B78A7E62DA89B8969F2DB5FF325580FD416C1789D1DB13C84E0F6B8E5B8271E7DA1A5C45A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2E4499203129ABA244B73B4B78A7E62DA89B8969F2DB5FF325580FD416C1789D1DB13C84E0F6B8E5B8271E7DA1A5C45A
http://www.w3.org/2000/01/rdf-schema#comment
"ASSP2 expression is lower in cancerous tissues and decreased ASPP2 lead to higher cancer cells proliferation and autophagic flux which contribute to the gemcitabine resistance."
xsd:string
http://purl.uniprot.org/uniprot/#_D0038A786BB14966717090EF7DFCD90806D8238008397A9D991AAFD83A783D1B087414469F7F2E50EDEACDE1B9681826
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2E4499203129ABA244B73B4B78A7E62DA89B8969F2DB5FF325580FD416C1789D1DB13C84E0F6B8E5B8271E7DA1A5C45A
http://purl.uniprot.org/uniprot/B4DH76
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E4499203129ABA244B73B4B78A7E62DA89B8969F2DB5FF325580FD416C1789D1DB13C84E0F6B8E5B8271E7DA1A5C45A
http://purl.uniprot.org/uniprot/#_B4DH76-mappedCitation-26438046
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E4499203129ABA244B73B4B78A7E62DA89B8969F2DB5FF325580FD416C1789D1DB13C84E0F6B8E5B8271E7DA1A5C45A